Latest Breaking News On - Stefano del prato - Page 1 : comparemela.com

Applied Therapeutics (APLT) to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

Applied Therapeutics (APLT) to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJaved butlerGregoryd lewisRiccardo perfettiFaiez zannadThomash marwickJulio rosenstockNasriene ibrahimJustina ezekowitzWh wilson tangJamesl januzzi jrAmerican college of cardiologyTherapeutics incJournal of the american college cardiologyApplied therapeuticsDiabetic cardiomyopathy

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMaeve conneightonNasriene ibrahimJamesl januzzi jrThomash marwickGregoryd lewisRiccardo perfettiJustina ezekowitzFaiez zannadAdvanz pharmaJaved butlerWh wilson tangJulio rosenstockTherapeutics incJournal of the american college cardiologyExchange commission

The push to include put diabetes at the heart of Europe s election manifestos – EURACTIV com

The push to include put diabetes at the heart of Europe s election manifestos – EURACTIV com
euractiv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euractiv.com Daily Mail and Mail on Sunday newspapers.

Eu diabetes forumEuropean unionEuropean diabetes forumDiabetes community pledgeEuropean parliamentDiabetes community pledgeStefano del pratoDel pratoEarly detectionEquitable careEmpowering peopleEmbracing science

Applied Therapeutics to Present Baseline Data on the Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at the 2023 Annual Meeting of the American Diabetes Association

The ongoing ARISE-HF Phase 3 global clinical trial is evaluating the safety and efficacy of AT-001 (caficrestat) in improving or preventing worsening of cardiac functional capacity in Diabetic Cardiomyopathy (DbCM); topline data from the study is expected.

United statesSan diegoJulio rosenstockAlessia urbinatiMaeve conneightonJamesl januzzi jrJustin ezekowitzFaiez zannadWh wilson tangNasriene ibrahimJaved butlerRiccardo perfettiUniversity of albertaMeeting of the american diabetes associationTherapeutics incExchange commission

Stockholm Calls: Docs Eye New Tactics for Type 2 Diabetes at EASD

New data on tirzepatide for weight loss and potential type 2 diabetes remission as well as an update on use of dapagliflozin for heart failure will be presented at the first in-person EASD meeting for 3 years.

United statesComunidad autonoma de catalunaEuropean association for the study of diabetesKarolinska instituteEuropean society of cardiologyUniversity of pisa school medicineEuropean associationStefano del pratoMedscape medicalDel pratoPisa schoolSecretary mikael rydDiabetes sideEuropean societyNew england journalWeight loss